Skip to content

Public FDA record

Z-0562-2021: BD" Multi-Check CD4 Low Control 2.5 mL IVD - Product Usage: intended as a complete process control for im

Recall record Z-0562-2021 for Becton, Dickinson and Company, BD Biosciences. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0562-2021
Company in FDA record
Becton, Dickinson and Company, BD Biosciences
FDA record creation date
Dec 10, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Recent product complaints showing an unexpected cell population exhibiting dim CD3 expression that may result in inaccurate results gating.

Source facts

Action
On 10/13/2020, the firm notified it customer via telephone and sent an "URGENT MEDICAL DEVICE RECALL" Notification via email and/or FedEx to inform them that complaints have been report regarding their Low Control product which shows an unexpected cell population exhibiting dim CD3 expression that may result in inaccurate gating with the potential for delayed patient management. Customer are instructed to: 1. Immediately review their inventory for the specific Catalog and lot numbers listed. Destroy all product subject to this recall following their institutions process for destruction. 2. Share this recall notification with all users of the product within their facility to ensure that they are also aware of this recall. 3. Complete the attached Customer Response Form and return to the Recalling Firm contact noted on the form. Even if customer do not have any of the affected lots in their inventory, they are asked to complete the Customer Recall Response Form indicating they have zero (0) quantity and return as indicated. Return Customer Response Form via email BDRC16@bd.com or fax 312-949-0371 Actions the Recalling Firm is taking: An investigation has been initiated to identify root cause and corrective actions to prevent recurrence. An questions, contact Customer/Technical Support at 877-232-8995 (prompt 2,2)
Initiated
2020-10-05
Root cause
Process control
Terminated
2022-03-11
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, CA, CO, CT, DE, FL, GA, IL, IN, KY, MA, MD, MI, NC, NJ, NV, NY, OH, OK, PA, PR, RI, SD, TN, TX, and VA. The countries of Canada, Belgium, Korea, India, Ecuador, Japan, Costa Rica, Australia, Vietnam, Pakistan, Singapore, Thailand, and Peru.
Recall number
Z-0562-2021
Recall status
Terminated
CDRH record ID
184263
FDA record created
2020-12-10
Recall event number
86655

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗